Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
Articolo
Data di Pubblicazione:
2015
Citazione:
Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study / Danese, S; Rudzinski, J; Brandt, W; Dupas, Jl; Peyrin-Biroulet, L; Bouhnik, Y; Kleczkowski, D; Uebel, P; Lukas, M; Knutsson, M; Erlandsson, F; Hansen, Mb; Keshav, S. - In: GUT. - ISSN 0017-5749. - 64:2(2015), pp. 243-249. [10.1136/gutjnl-2014-308004]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Danese, S; Rudzinski, J; Brandt, W; Dupas, Jl; Peyrin-Biroulet, L; Bouhnik, Y; Kleczkowski, D; Uebel, P; Lukas, M; Knutsson, M; Erlandsson, F; Hansen, Mb; Keshav, S
Link alla scheda completa:
Pubblicato in: